LeMaitre Vascular
LMAT
220 hedge funds and large institutions have $1.06B invested in LeMaitre Vascular in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 94 increasing their positions, 71 reducing their positions, and 21 closing their positions.
2,945% more call options, than puts
Call options by funds: $670K | Put options by funds: $22K
43% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 21
32% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 71
4% more funds holding
Funds holding: 212 → 220 (+8)
1.71% more ownership
Funds ownership: 85.81% → 87.51% (+1.7%)
16% less capital invested
Capital invested by funds: $1.27B → $1.06B (-$206M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$4.36M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$4.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.1M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$3.06M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.95M |
LMAT Hedge Fund Activity: Q3 2023 in Review
220 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2023, worth a combined $1.06B — down 16% from $1.27B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new LMAT positions and 21 closed out — a net gain of 9 holders — while 94 added to existing stakes and 71 trimmed.
The largest buyer was Congress Asset Management, adding an estimated $8.02M. The largest seller was Millennium Management, cutting an estimated $4.36M.
- 220 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2023, up from 212 in Q2 2023.
- Funds reported $1.06B of LeMaitre Vascular stock for Q3 2023, down 16% quarter-over-quarter.
- 30 funds opened new LeMaitre Vascular positions in Q3 2023 and 21 closed out, a net change of +9 holders.
- The largest LeMaitre Vascular buyer in Q3 2023 was Congress Asset Management, an estimated $8.02M added.
- The largest LeMaitre Vascular seller in Q3 2023 was Millennium Management, an estimated $4.36M sold.
Based on aggregated 13F filings for Q3 2023.